Development and Establishment of the PRECISION-ON (Prostate cancer Research and Equity Collaborative for Innovations in Screening, Intervention, and Outcomes in Ontario)
Study Status: active
Institute: Princess Margaret Cancer Centre
Study Purpose: The study aims to establish an advisory group called PRECISION-ON. This group aims to improve prostate cancer screening in Ontario. The goal is to develop more equitable, personalized screening methods. The project is exploring the use of tools, like artificial intelligence (AI), while working closely with patients and communities to ensure the work reflects real-world needs.
Background: Prostate cancer is the most common non-skin cancer and a leading cause of cancer death among Canadian men. Not everyone has equal access to screening and care. People from racial and ethnic minority groups, people with lower incomes, and people who have trouble understanding health information are screened less often. Today’s screening approaches don’t fully take these differences into account. There is a need to involve patients and communities to better understand these gaps and improve screening in a fair way.
Study Methods: PRECISION-ON will bring together patients, community leaders, and experts to guide the work. The group will:
* Share experiences and perspectives on prostate cancer screening
* Help identify and refine research priorities
* Explore how AI can be used to create more fair and personalized prostate cancer screening strategies
* Co-develop research and policy ideas focused on prostate cancer health equity
* Provide feedback on materials to ensure they are clear and relevant
Health Conditions:
Cancer